Lara Dötsch

Statistics

Publications

Citations

200

H-Index

Active since

2020

Affiliations

Max Planck Institute of Molecular Physiology(Current)

TU Dortmund University

Austrian Academy of Sciences

CeMM Research Center for Molecular Medicine

Lara Dötsch is an author at Max Planck Institute of Molecular Physiology specializing in medicinal chemistry, medicinal chemistry applications, and drug discovery.

ORCID

Publications per year

2020–2024

Publications

Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket

Hacer Karataş, Mohammad Akbarzadeh, Hélène Adihou et al. · Journal of Medicinal Chemistry · 2020 · 65 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype

Gang Xue, Jianing Xie, Matthias Hinterndorfer et al. · Nature Communications · 2023 · 49 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

Identification of a Novel Pseudo‐Natural Product Type IV IDO1 Inhibitor Chemotype

Caitlin Davies, Lara Dötsch, Maria Gessica Ciulla et al. · Angewandte Chemie International Edition · 2022 · 32 citations · Full text

Pharmacy, Chemical Biology, Medicinal Chemistry +17

The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation

Jana Flegel, Saad Shaaban, Zhi Jun Jia et al. · Journal of Medicinal Chemistry · 2022 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Cell‐Based Identification of New IDO1 Modulator Chemotypes

Elisabeth Hennes, Philipp Lampe, Lara Dötsch et al. · Angewandte Chemie International Edition · 2021 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

1–5 of 6